Evaluation of Reactogenicity and Neutralizing Antibody Responses 6 Months Post-Vaccination with Monovalent COVID-19 Vaccine.

Comirnaty (tozinameran) - Pfizer, BioNTech

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/40784737

Euijin Chang; Hye Hee Cha; Ji Yeon Kim; Ji-Soo Kwon; Jiwon Jung; Min Jae Kim; Sang-Ho Choi; Sang-Oh Lee; Seongman Bae; So Yun Lim; Sung-Han Kim; Yang Soo Kim; Yong Pil Chong

Aug 11, 2025